Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol versus nitroglycerin for controlled hypotension and bleeding reduction during septorhinoplasty
IRCT2014021712094N4Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of labetalol and nitroglycerin (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: blood pressure control and bleeding reduction. Started Dec 2013; status: completed.
02
Drugs
labetalolnitroglycerin
Beyond the preview
Go deeper on IRCT2014021712094N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014021712094N4.